The report is updated with the impact of the COVID-19 pandemic on the Neurodiagnostics market. Every industry vertical across the globe has been affected by the pandemic, and the report assesses if the impact of the pandemic on the Neurodiagnostics market has been positive or negative.
Emergen Research has recently published a detailed report on the global Neurodiagnostics market formulated through extensive primary and secondary research. The report offers in-depth knowledge and analysis of the Neurodiagnostics market through verified and validated data curated to offer accurate insights.
The global neurodiagnostics market size is expected to reach USD 14.83 Billion and register a steady revenue CAGR of 7.3% in 2032, according to latest analysis by Emergen Research. Neurodiagnostics market revenue growth is expected to be driven by increasing patient awareness and focus on early disease detection. For instance, on 09 February 2023, it was announced that QuantalX Neuroscience Ltd. and NeuroSense Therapeutics Ltd. will work together to advance the early detection and treatment of neurodegenerative illnesses. QuantalX Neuroscience Ltd. is an organization that develops drugs for the clinical stage. With the help of real-time brain functioning monitoring, QuantalX's Delphi-MD is a ground-breaking medical device that bridges the neurodiagnostic gaps that clinicians face at the point of treatment, improving patient care and lowering related costs.
Get Free Sample Report @ https://www.emergenresearch.com/request-sample/1786
The report further divides the Neurodiagnostics market into key segments such as types, applications, end-user industries, technologies, and key regions of the market. The report also sheds light on the segment and region exhibiting promising growth in the Neurodiagnostics market.
Neurodiagnostics Market Segmentation:
-
Product Outlook (Revenue, USD Billion; 2019–2032)
- Diagnostic and Imaging Systems
- Electroencephalogram (EEG) Systems
- Electromyography (EMG) Products
- Magnetic Resonance Imaging (MRI) Systems
- Ultrasound Imaging Systems
- Computed Tomography (CT) Scanner
- Magnetoencephalogram (MEG) System
- Position emission tomography (PET) System
- Angiography System
- Others
- Clinical Testing Instruments
- PCR
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Others
- Reagents & Consumables
- Media and Serra
- Solvents
- Enzymes, Protein & Peptides
- Probes
- Buffers
- Antibodies
- Others
- Diagnostic and Imaging Systems
-
Condition Outlook (Revenue, USD Billion; 2019–2032)
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- Others
-
End-Use Outlook (Revenue, USD Billion; 2019–2032)
- Hospitals and Surgery Centers
- Neurology Centers
- Ambulatory Care Centers
- Diagnostic Laboratories & Imaging Centers
- Research Laboratories & Academic Institutes
Request a discount on the report @ https://www.emergenresearch.com/request-discount/1786
The report also studies the key companies of the Neurodiagnostics market along with analysis of their business strategies, M&A activities, investment plans, product portfolio, financial standing, gross profit margin, and production and manufacturing capacities. Some players analyzed in the report are:
Key companies operating in the Neurodiagnostics market include:
GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Hitachi, Ltd., Canon Inc., Lifelines Neuro, Natus Medical Incorporated, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, Mitsar Co. LTD
The Global Neurodiagnostics Report is a panoramic study of the overall Neurodiagnostics market published by Emergen Research and covers a wide-ranging analysis of the technological advancements and product developments in the Neurodiagnostics market. The report provides a detailed analysis of the key factors of the Neurodiagnostics market that are expected to have a positive impact on the growth of the Neurodiagnostics industry.
Regional Segmentation
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The report further examines the market in the key regions of the world with regard to production and consumption patterns, import/export, supply and demand ratio, revenue generation, market share and size, and presence of prominent players in the regions. The report also covers the expansion plans undertaken by companies in the regions under the regional analysis section.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/neurodiagnostics-market
Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights